First human tests begin for experimental hypertension pill
NCT ID NCT07152444
Summary
This is an early Phase 1 study to check the safety and basic effects of a new oral drug called QLS1410 for high blood pressure. It will enroll 78 healthy Chinese adults and people with mild hypertension to test different single and repeated doses. The main goal is to see how the body processes the drug and to identify any side effects before larger studies can begin.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNCONTROLLED HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University Third Hospital
Beijing, China
Conditions
Explore the condition pages connected to this study.